
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Balance between immunoregulatory B cells and plasma cells drives pancreatic tumor immunity
Bhalchandra Mirlekar, Yan Wang, Sirui Li, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 9, pp. 100744-100744
Open Access | Times Cited: 41
Bhalchandra Mirlekar, Yan Wang, Sirui Li, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 9, pp. 100744-100744
Open Access | Times Cited: 41
Showing 1-25 of 41 citing articles:
Tertiary lymphoid structures and B cells: An intratumoral immunity cycle
Wolf H. Fridman, Maxime Meylan, Guilhem Pupier, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2254-2269
Open Access | Times Cited: 116
Wolf H. Fridman, Maxime Meylan, Guilhem Pupier, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2254-2269
Open Access | Times Cited: 116
B cells in the tumor microenvironment: Multi-faceted organizers, regulators, and effectors of anti-tumor immunity
Céline M. Laumont, Brad H. Nelson
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 466-489
Open Access | Times Cited: 92
Céline M. Laumont, Brad H. Nelson
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 466-489
Open Access | Times Cited: 92
Methylation across the central dogma in health and diseases: new therapeutic strategies
Ruochen Liu, Erhu Zhao, Huijuan Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 56
Ruochen Liu, Erhu Zhao, Huijuan Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 56
Current and future immunotherapeutic approaches in pancreatic cancer treatment
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 36
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 36
Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept
Wenyu Luo, Ti Wen, Xiujuan Qu
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 24
Wenyu Luo, Ti Wen, Xiujuan Qu
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 24
Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma
Shailendra K. Gautam, Surinder K. Batra, Maneesh Jain
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 39
Shailendra K. Gautam, Surinder K. Batra, Maneesh Jain
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 39
Gut epithelial Interleukin-17 receptor A signaling can modulate distant tumors growth through microbial regulation
Vidhi Chandra, Le Li, Olivereen Le Roux, et al.
Cancer Cell (2023) Vol. 42, Iss. 1, pp. 85-100.e6
Open Access | Times Cited: 29
Vidhi Chandra, Le Li, Olivereen Le Roux, et al.
Cancer Cell (2023) Vol. 42, Iss. 1, pp. 85-100.e6
Open Access | Times Cited: 29
Spatial Transcriptomics of Intraductal Papillary Mucinous Neoplasms of the Pancreas Identifies NKX6-2 as a Driver of Gastric Differentiation and Indolent Biological Potential
Marta Sans, Yuki Makino, Jimin Min, et al.
Cancer Discovery (2023) Vol. 13, Iss. 8, pp. 1844-1861
Open Access | Times Cited: 24
Marta Sans, Yuki Makino, Jimin Min, et al.
Cancer Discovery (2023) Vol. 13, Iss. 8, pp. 1844-1861
Open Access | Times Cited: 24
Autotaxin–lysolipid signaling suppresses a CCL11–eosinophil axis to promote pancreatic cancer progression
Sohinee Bhattacharyya, Chet Oon, Luis Diaz, et al.
Nature Cancer (2024) Vol. 5, Iss. 2, pp. 283-298
Open Access | Times Cited: 12
Sohinee Bhattacharyya, Chet Oon, Luis Diaz, et al.
Nature Cancer (2024) Vol. 5, Iss. 2, pp. 283-298
Open Access | Times Cited: 12
Barriers and opportunities in pancreatic cancer immunotherapy
Yixin Ju, Dongzhi Xu, Miao-Miao Liao, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 11
Yixin Ju, Dongzhi Xu, Miao-Miao Liao, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 11
Germinal center-dependent and -independent immune responses of tumor-infiltrating B cells in human cancers
Eve Playoust, Romain Remark, Éric Vivier, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 9, pp. 1040-1050
Open Access | Times Cited: 20
Eve Playoust, Romain Remark, Éric Vivier, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 9, pp. 1040-1050
Open Access | Times Cited: 20
The Dual Role of B Cells in the Tumor Microenvironment: Implications for Cancer Immunology and Therapy
Hao Yang, Zhiru Zhang, Jijun Li, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11825-11825
Open Access | Times Cited: 6
Hao Yang, Zhiru Zhang, Jijun Li, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11825-11825
Open Access | Times Cited: 6
Immunometabolic reprogramming, another cancer hallmark
Vijay Kumar, John H. Stewart
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Vijay Kumar, John H. Stewart
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Exploring the dual role of B cells in solid tumors: implications for head and neck squamous cell carcinoma
Jiantong Bao, Annika Betzler, Jochen Heß, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Jiantong Bao, Annika Betzler, Jochen Heß, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Plasma cell signatures predict prognosis and treatment efficacy for lung adenocarcinoma
Long Shu, Jun Tang, Shuang Liu, et al.
Cellular Oncology (2023) Vol. 47, Iss. 2, pp. 555-571
Closed Access | Times Cited: 14
Long Shu, Jun Tang, Shuang Liu, et al.
Cellular Oncology (2023) Vol. 47, Iss. 2, pp. 555-571
Closed Access | Times Cited: 14
Navigating the immune landscape with plasma cells: A pan‐cancer signature for precision immunotherapy
Bicheng Ye, Aimin Jiang, Liang Feng, et al.
BioFactors (2024)
Closed Access | Times Cited: 5
Bicheng Ye, Aimin Jiang, Liang Feng, et al.
BioFactors (2024)
Closed Access | Times Cited: 5
The EPH/Ephrin System in Pancreatic Ductal Adenocarcinoma (PDAC): From Pathogenesis to Treatment
Stavros P. Papadakos, Nikolaos Dedes, Nikolina Gkolemi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 3015-3015
Open Access | Times Cited: 11
Stavros P. Papadakos, Nikolaos Dedes, Nikolina Gkolemi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 3015-3015
Open Access | Times Cited: 11
Protocol for in vivo immune cell analysis in subcutaneous murine tumor models using advanced flow cytometry
Katrine Ingelshed, Marit M. Melssen, Diana Spiegelberg
STAR Protocols (2025) Vol. 6, Iss. 1, pp. 103505-103505
Closed Access
Katrine Ingelshed, Marit M. Melssen, Diana Spiegelberg
STAR Protocols (2025) Vol. 6, Iss. 1, pp. 103505-103505
Closed Access
Multifaceted function of B cells in tumorigenesis
Na Kang, Qinghui Duan, Xin Min, et al.
Frontiers of Medicine (2025)
Closed Access
Na Kang, Qinghui Duan, Xin Min, et al.
Frontiers of Medicine (2025)
Closed Access
Bidirectional Mendelian randomization and potential mechanistic insights into the causal relationship between gut microbiota and malignant mesothelioma
Yinjie Zhou, Huangkai Zhu, Long Zhao, et al.
Medicine (2025) Vol. 104, Iss. 17, pp. e42245-e42245
Open Access
Yinjie Zhou, Huangkai Zhu, Long Zhao, et al.
Medicine (2025) Vol. 104, Iss. 17, pp. e42245-e42245
Open Access
Neoadjuvant chemotherapy is associated with suppression of the B cell-centered immune landscape in pancreatic ductal adenocarcinoma
Luise Rupp, Ina Dietsche, Maximilian Kießler, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Luise Rupp, Ina Dietsche, Maximilian Kießler, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
The Evolving Landscape of B Cells in Cancer Metastasis
Monika J. Ramos, Asona Lui, Daniel P. Hollern
Cancer Research (2023) Vol. 83, Iss. 23, pp. 3835-3845
Open Access | Times Cited: 7
Monika J. Ramos, Asona Lui, Daniel P. Hollern
Cancer Research (2023) Vol. 83, Iss. 23, pp. 3835-3845
Open Access | Times Cited: 7
Single-cell RNA sequencing highlights epithelial and microenvironmental heterogeneity in malignant progression of pancreatic ductal adenocarcinoma
Jin Li, Tao Wei, Ke Ma, et al.
Cancer Letters (2024) Vol. 584, pp. 216607-216607
Closed Access | Times Cited: 2
Jin Li, Tao Wei, Ke Ma, et al.
Cancer Letters (2024) Vol. 584, pp. 216607-216607
Closed Access | Times Cited: 2
Current understanding of the immune potential of B-cell subsets in malarial pathogenesis
Meenu Kalkal, Jyoti Das
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 4
Meenu Kalkal, Jyoti Das
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 4
Top advances of the year: Pancreatic cancer
Emilie A. K. Warren, Gregory B. Lesinski, Shishir K. Maithel
Cancer (2023) Vol. 129, Iss. 24, pp. 3843-3851
Open Access | Times Cited: 4
Emilie A. K. Warren, Gregory B. Lesinski, Shishir K. Maithel
Cancer (2023) Vol. 129, Iss. 24, pp. 3843-3851
Open Access | Times Cited: 4